Search - tctmd.com

Displaying 141 - 160 of 162

Sort: Relevancy | Date

Presentation SOLACI 2013

Imaging Evaluation of ISR

Presenter: Jos? de Ribamar Costa Jr.

July 25, 2013

Presentation TVT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

June 13, 2013

Presentation EuroPCR 2013

PEPCAD China ISR

Presenter: Run-Lin Gao

May 23, 2013

Presentation TCT 2013

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2013

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Percutaneous Coronary Intervention In A Complex Patient Population: A Comparison of First- versus Second-Generation Drug-Eluting Stent Use On In-Hospital and 1-Year Outcomes

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Impact Of Clinical Presentation On In-Hospital Bleeding Outcomes In Percutaneous Coronary Intervention

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

Presenter: Hironori Kitabata, Joshua Loh, Gabriel Sardi, Salem Badr, Danny Dvir, Israel Barbash, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2012

Case 2: Management of DES ISR with Drug Eluting Balloons

Presenter: Andrzej Ochala

October 26, 2012

Presentation TCT 2012

Case 1: Management of Focal DES ISR

Presenter: Ioannis Iakovou

October 26, 2012

Presentation TCT 2012

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Presenter: Antonio Colombo

October 25, 2012

Presentation TCT 2012

Coronary ISR: An Accepted Clinical Indication in the DES World?

Presenter: Huay Cheem Tan

October 25, 2012

Presentation TCT 2012

The Israeli "Start-up Nation" Approach to Medical Innovation: Defining the Ecosystem

Presenter: Ran Kornowski

October 22, 2012

Presentation TCT 2012

The "Hottest" New Cardiovascular Device Concepts from the Israeli Innovation Pipeline

Presenter: Chaim Lotan

October 22, 2012

Presentation TVT 2012

Israeli Perspectives on Defining the High-Risk Patient Suitable for TAVR

Presenter: Ran Kornowski

June 05, 2012

Presentation

Resultados Clínicos y Tratamiento tras Fracaso de SLF: Ausencia de Factores de Riesgo Tradicionales en la Reestenosis Intra Stent (ISR)

Presenter: G. Maluenda

February 15, 2012

Presentation

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Presenter: G. Maluenda

February 15, 2012

Presentation TCT 2012

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Presenter: Israel M. Barbash, Rebecca Torgusson, Itsik Ben-Dor, Gabriel Maluenda, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Advertisement

Imaging Evaluation of ISR

The Valve Medical TAVR System (Israel)

PEPCAD China ISR

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Percutaneous Coronary Intervention In A Complex Patient Population: A Comparison of First- versus Second-Generation Drug-Eluting Stent Use On In-Hospital and 1-Year Outcomes

Impact Of Clinical Presentation On In-Hospital Bleeding Outcomes In Percutaneous Coronary Intervention

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

Case 2: Management of DES ISR with Drug Eluting Balloons

Case 1: Management of Focal DES ISR

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Coronary ISR: An Accepted Clinical Indication in the DES World?

The Israeli "Start-up Nation" Approach to Medical Innovation: Defining the Ecosystem

The "Hottest" New Cardiovascular Device Concepts from the Israeli Innovation Pipeline

Israeli Perspectives on Defining the High-Risk Patient Suitable for TAVR

Resultados Clínicos y Tratamiento tras Fracaso de SLF: Ausencia de Factores de Riesgo Tradicionales en la Reestenosis Intra Stent (ISR)

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content